Form 4 for MGNX MACROGENICS INC
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-08 · accession 0001125345-25-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-11 | 2025-02-08 | MGNX | Koenig Scott | Pres, CEO, Dir | A - Grant | $0.00 | +31.7K | 735.1K | +5% | $0 |
| D | 2025-02-11 | 2025-02-08 | MGNX | Koenig Scott | Pres, CEO, Dir | M - OptEx | $0.00 | -31.7K | 63.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-08 | A | A | 31,673 | $0.00 | 735,086 | D | — | — | (F1) On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2025-02-08 | M | D | 31,673 | $0.00 | 63,327 | D | — · — to — | 31,673 Common Stock | (F1) On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |